Biotech

104 stories
Raise for Raze

Cambridge-based Raze Therapeutics announced its launch Monday, adding that it has closed on a $24 million Series A financing.

Investors in the Series A financing include Atlas Venture, MPM Capital Management, MS Ventures, Partners Innovation Fund, Astellas Venture Management, and Novartis, the Raze press release said.

Atlas partner Jason Rhodes is Raze’s acting chief executive.

Read more at BostonGlobe.com...

Discuss
Tipping point
Kendall Square passes from tech center to biotech center
Shannon Pendergrast of Ymir Genomics isolates exosomes from biofluids at LabCentral in Cambridge’s Kendall Square. (Wendy Maeda/Globe Staff)
The three-story brick building at the corner of Main and Osborn streets in Cambridge, on the edge of Kendall Square and the MIT campus, captures three distinct eras in the city’s innovation history. In the early 1800s, it was the site of Kimball & Davenport, the first builder of passenger railroad cars in America. Read More
The French Connection
Backed by Gov. Patrick, Mass. tech organizations announce a flurry of strategic links in France
Image of View on Eiffel Tower, Paris, France via Shutterstock
In a series of partnerships that echoes the days when the Siemens brothers helped stretch transatlantic cables from Cape Cod to the French coast, organizations from the Commonwealth of Massachusetts are connecting with counterparts in the French Republic to push technology and innovation forward in both Boston and Paris. Last week ended with a flurry of announcements and news involving the strategic tech partnerships being formed between the Boston tech community and the burgeoning Paris innovation ecosystem. Read More